667403-46-5

Basic information

• Product Name: CHEMBRDG-BB 7959525
• Synonyms: CHEMBRDG-BB 7959525;N-(2,5-DICHLOROBENZOYL)GLYCINE;UKRORGSYN-BB BBV-048921;N-(2,5-dichlorobenzoyl)glycine(SALTDATA: FREE);2-(2,5-dichlorobenzamido)acetic acid;2-[(2,5-dichlorobenzoyl)amino]acetic acid;(2,5-dichlorobenzoyl)glycine;5-Dichlorobenzoyl)glycine
• CAS NO: 667403-46-5
• Molecular Formula: C₉H₇Cl₂NO₃
• Molecular Weight: 248.064
• EINECS: 1592732-453-0
• Mol File: 667403-46-5.mol
• Article Data: 20

Chemical Properties

• Boiling Point: 420.6°C at 760 mmHg
• Flash Point: 208.2°C
• Appearance: /
• Density: 1.505g/cm³
• Vapor Pressure: 7.93E-08mmHg at 25°C
• Refractive Index: 1.593
• Storage Temp.: 2-8°C
• PKA: 3.63±0.10(Predicted)
• CAS DataBase Reference: CHEMBRDG-BB 7959525(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMBRDG-BB 7959525(667403-46-5)
• EPA Substance Registry System: CHEMBRDG-BB 7959525(667403-46-5)

Safety Data

• Hazardous Substances Data: 667403-46-5(Hazardous Substances Data)

Usage

Uses

N-(2,5-Dichlorobenzoyl)glycine is an amino acid derivative.

InChI:InChI=1/C9H7Cl2NO3/c10-5-1-2-7(11)6(3-5)9(15)12-4-8(13)14/h1-3H,4H2,(H,12,15)(H,13,14)

Upstream product

• 56-40-6 glycine 
• 2905-61-5 2,5-dichlorobenzoyl chloride 
• 6000-43-7 2-aminoethanoic acid hydrochloride 
• 50-79-3 2,5-dichlorobenzoic acid 

Downstream Products

• 1201903-02-7 2,5-dichloro-N-[2-({(1R)-3-methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexa-hydro-2H-4,6-methano-1,3,2-benzodioxaborol-2-yl]butyl}amino)-2-oxoethyl]benzamide 
• 1239908-20-3 2,2’-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid 
• 1072833-77-2 Ixazomib 

Relevant articles and documents

p53 DEGRADATION INDUCING MOLECULE AND PHARMACEUTICAL COMPOSITION

A p53 degradation inducing molecule which can induce degradation of p53 proteins or p53 composites, and a pharmaceutical composition containing said p53 degradation inducing molecule are provided. This p53 degradation inducing molecule is a conjugate of a p53 affinity molecule which has affinity for p53 proteins or p53 composites, and a proteolysis induction tag which has affinity for protease and which does not inhibit proteolysis of proteins by protease.

PROCESS FOR MAKING IXAZOMIB OR INTERMEDIATES THEREFOR

This invention relates to a process for preparing Ixazomib 1, its trimer 1.trimer, its citrate ester 2 or an intermediate for their synthesis. The process comprising at least one amide coupling reaction in the presence of a cyclic alkyl triphosphonic anhy

Synthetic process research of ixazomib

The invention discloses a synthesis method of ixazomib. The yield and the purity of a target product can be greatly increased with the method.